chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Nasal congestion, Pericardial effusion, SARS-CoV-2 test positive
Clinical narrative: I was traveling out of state and returned on 10/17/2022. That night I ended up in the hospital with fluid on my heart. I was admitted in the hospital for 3 days. I am diabetic and have been on a very low salt diet, but while traveling, I was unable to abide by that diet. While in the hospital they treated me with LAsix and insulin and informed me that they thought my issue was due to my poor diet and lack of activity while traveling. They didn't test me for COVID-19 in the hospital. On Friday, I was informed that a friend tested positive for COVID-19. So, I tested myself and was also positive. I tested again on Sunday and was still positive. I had a little bit of stuffiness on Friday and had a bit of an irritated cough but no fever or loss of appetite or senses. By Sunday, when I woke up, even those symptoms were gone. Now, I am only experiencing an occasional cough, but even that is almost nonexistent. Everything was so mild; it didn't even feel like a cold.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a Pediatric vaccine that had wrong expiration date on the label but the actual expiration date was 09/30/2022. They received the vaccine on 10/09/2022. I have not heard any complaint from the parent
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Injection site pain, No adverse event
Clinical narrative: This event was caused by human error. The nurse inadvertently administered the Moderna Bivalent dose to patient instead of the primary dose. Patient was monitored for 15 minutes and did not show any adverse side effects. The patient was contacted on 10/13/2022 by the Chief Operations Officer and the patient indicated that he had no  symptoms except soreness at the site of injection.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Heart rate increased, Palpitations
Clinical narrative: She got her vaccine, nothing, had no reaction and has never had any problems with any vaccines.  About 9:00 PM she went to work and all at once she started to feel bad, shortness of breath.  She had 3 hours to go and kept going and went home and went straight to bed.  She was breathing heavy and got up about 5:00 AM and ate something as she had not eaten much the day before.  She was sitting at the table and could see her f\FITbit going up and up and going faster.  She looked up what to do for a fast heartbeat, and it said to lay down, which she went back to bed.  She did not know how high it got and was huffing and puffing.  She does not know how long it took for her heart to stop racing and was so short of breath.  The rest of the day she was wiped out and continued to huff and puff.  The next day it was a little better but felt like she was drug through the ringer and was still a little short of breath.  By Saturday she was back to normal.  She did see an ad about pericarditis and continued to take in fluids, and she is fine now.   She did also get her flu shot on the same day. She did not have any soreness in her arms from the vaccines.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: The influenza vaccine Fluarix was administered after a temperature excursion that the vaccine was not viable.
Age: 69.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: COVID-19, Cough, Influenza A virus test negative, Influenza B virus test, Myalgia
Clinical narrative: Viral URI with cough,  Dry Cough, Myalgia and Covid-19
Age: 69.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: SARS-CoV-2 test positive, Viral upper respiratory tract infection
Clinical narrative: Viral URI with cough,  Dry Cough, Myalgia and Covid-19
Age: 78.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: pt already received high dose fluzone 10/05/2022
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Herpes zoster
Clinical narrative: Shingles.Right lower Leg
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: This event was caused by human error. The nurse inadvertently administered the Moderna Bivalent dose to patient instead of the primary dose. Patient was monitored for 15 minutes and did not show any adverse side effects. The patient did not have access to a cell phone. A message was left for the director on 10/15/2022 to follow-up on the patient however, a callback was never received.
Age: 19.0
Sex: M
Vaccine: TYP, YF
Symptoms: Urticaria, Vomiting
Clinical narrative: Vomiting and hives on day of vaccine
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, COVID-19, COVID-19 pneumonia, Cardiac failure acute
Clinical narrative: COVID + 10/15/22 - Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/15/2022 Discharge Date: Oct 17, 2022  Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 92-year-old man with past medical history significant for  diastolic HF, CAD s/p CABG, atrial flutter s/p ablation, HTN, HLD and BPH who presented to the ED with cough and shortness of breath.  Was saturating 76% o on room air in the emergency department and placed on 2 L which subsequently improved to 90%.  COVID-19 PCR was positive. CXR showing mediastinal widening likely due to goiter, no airspace consolidation or effusions.  Admitted with acute respiratory insufficiency with hypoxia, treatment for COVID-19 pneumonia.  CT angiogram thorax demonstrated no pulmonary embolism, without any pulmonary consolidation or pleural effusions, worsening thyromegaly with left lower retrosternal extension, tracheal deviation, , known due to mass effect from above (tracheal diameter 1 cm previously 1.3 cm in 2019). Possible tracheal bronchomalacia.  Findings were shared with ENT who recommended outpatient follow-up only.  Patient was started on Decadron, remdesivir for COVID 19 PCR and continue with IV diuresis.  Patient's hypoxia quickly resolved and he was no longer supplemental oxygen.  IV Lasix was transitioned back to his home dose furosemide at discharge.  Patient was discharged on oral Decadron.  Id patient was evaluated by SLP who showed no significant dysphagia and recommended no further SLP intervention.  Patient was evaluated by PT and OT recommended home with assist.  Patient was subsequent discharged home in medically stable condition.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chest X-ray abnormal, Condition aggravated, Cough, Dyspnoea
Clinical narrative: COVID + 10/15/22 - Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/15/2022 Discharge Date: Oct 17, 2022  Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 92-year-old man with past medical history significant for  diastolic HF, CAD s/p CABG, atrial flutter s/p ablation, HTN, HLD and BPH who presented to the ED with cough and shortness of breath.  Was saturating 76% o on room air in the emergency department and placed on 2 L which subsequently improved to 90%.  COVID-19 PCR was positive. CXR showing mediastinal widening likely due to goiter, no airspace consolidation or effusions.  Admitted with acute respiratory insufficiency with hypoxia, treatment for COVID-19 pneumonia.  CT angiogram thorax demonstrated no pulmonary embolism, without any pulmonary consolidation or pleural effusions, worsening thyromegaly with left lower retrosternal extension, tracheal deviation, , known due to mass effect from above (tracheal diameter 1 cm previously 1.3 cm in 2019). Possible tracheal bronchomalacia.  Findings were shared with ENT who recommended outpatient follow-up only.  Patient was started on Decadron, remdesivir for COVID 19 PCR and continue with IV diuresis.  Patient's hypoxia quickly resolved and he was no longer supplemental oxygen.  IV Lasix was transitioned back to his home dose furosemide at discharge.  Patient was discharged on oral Decadron.  Id patient was evaluated by SLP who showed no significant dysphagia and recommended no further SLP intervention.  Patient was evaluated by PT and OT recommended home with assist.  Patient was subsequent discharged home in medically stable condition.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Goitre, Hypoxia, Mediastinal disorder, Polyuria, SARS-CoV-2 test positive
Clinical narrative: COVID + 10/15/22 - Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/15/2022 Discharge Date: Oct 17, 2022  Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 92-year-old man with past medical history significant for  diastolic HF, CAD s/p CABG, atrial flutter s/p ablation, HTN, HLD and BPH who presented to the ED with cough and shortness of breath.  Was saturating 76% o on room air in the emergency department and placed on 2 L which subsequently improved to 90%.  COVID-19 PCR was positive. CXR showing mediastinal widening likely due to goiter, no airspace consolidation or effusions.  Admitted with acute respiratory insufficiency with hypoxia, treatment for COVID-19 pneumonia.  CT angiogram thorax demonstrated no pulmonary embolism, without any pulmonary consolidation or pleural effusions, worsening thyromegaly with left lower retrosternal extension, tracheal deviation, , known due to mass effect from above (tracheal diameter 1 cm previously 1.3 cm in 2019). Possible tracheal bronchomalacia.  Findings were shared with ENT who recommended outpatient follow-up only.  Patient was started on Decadron, remdesivir for COVID 19 PCR and continue with IV diuresis.  Patient's hypoxia quickly resolved and he was no longer supplemental oxygen.  IV Lasix was transitioned back to his home dose furosemide at discharge.  Patient was discharged on oral Decadron.  Id patient was evaluated by SLP who showed no significant dysphagia and recommended no further SLP intervention.  Patient was evaluated by PT and OT recommended home with assist.  Patient was subsequent discharged home in medically stable condition.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Tracheal deviation
Clinical narrative: COVID + 10/15/22 - Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/15/2022 Discharge Date: Oct 17, 2022  Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 92-year-old man with past medical history significant for  diastolic HF, CAD s/p CABG, atrial flutter s/p ablation, HTN, HLD and BPH who presented to the ED with cough and shortness of breath.  Was saturating 76% o on room air in the emergency department and placed on 2 L which subsequently improved to 90%.  COVID-19 PCR was positive. CXR showing mediastinal widening likely due to goiter, no airspace consolidation or effusions.  Admitted with acute respiratory insufficiency with hypoxia, treatment for COVID-19 pneumonia.  CT angiogram thorax demonstrated no pulmonary embolism, without any pulmonary consolidation or pleural effusions, worsening thyromegaly with left lower retrosternal extension, tracheal deviation, , known due to mass effect from above (tracheal diameter 1 cm previously 1.3 cm in 2019). Possible tracheal bronchomalacia.  Findings were shared with ENT who recommended outpatient follow-up only.  Patient was started on Decadron, remdesivir for COVID 19 PCR and continue with IV diuresis.  Patient's hypoxia quickly resolved and he was no longer supplemental oxygen.  IV Lasix was transitioned back to his home dose furosemide at discharge.  Patient was discharged on oral Decadron.  Id patient was evaluated by SLP who showed no significant dysphagia and recommended no further SLP intervention.  Patient was evaluated by PT and OT recommended home with assist.  Patient was subsequent discharged home in medically stable condition.
Age: 57.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Body temperature increased, Bronchitis, Cough, Influenza virus test positive, Pain
Clinical narrative: As of 10/07/2022, I experienced achiness, a low grade flu temperature, and cough. I tested negative for COVID-19 three times. But I tested positive for strep throat and flu on 10/09/2022. I was given AUGMENTIN steroids. I was also wheezing and I was given a 5 day course of steroids. My symptoms worsened and I went back to the doctor. I was given Z-PAK. I was diagnosed with Bronchitis as well.
Age: 57.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test negative, Streptococcus test positive, Wheezing
Clinical narrative: As of 10/07/2022, I experienced achiness, a low grade flu temperature, and cough. I tested negative for COVID-19 three times. But I tested positive for strep throat and flu on 10/09/2022. I was given AUGMENTIN steroids. I was also wheezing and I was given a 5 day course of steroids. My symptoms worsened and I went back to the doctor. I was given Z-PAK. I was diagnosed with Bronchitis as well.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: patient has rash all over the body after receiving the vaccine
Age: 15.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Influenza like illness, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: Flu like symptoms mild fever and fatigue that lasted thirty six hours and the on 14OCTOBER 2022 flu like symptoms that lasted seven days and included fever of 104 degrees for two days, severe congestion, fatigue.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bundle branch block left, Chest X-ray normal, Cough, Dysphonia, Electrocardiogram abnormal
Clinical narrative: I received the Moderna Bivalent AS7162B Vaccine 9-14-22 at the public health clinic. Within days I began experiencing hoarseness and coughing. A key symptom date was 10-10-22. For several years I have checked and recorded blood pressure and pulse rates twice a day. On 10/10/22 my pulse rate made a notable increase. For purposes of comparison, I averaged the pulse rate for 15 days (30 readings) immediately preceding 10-10-22. That average was 73. I then measured pulse ratings for 15 days (30 readings) starting with 10-10-22. That average was 83.   My symptoms (inability to sing, pray audibly, or read out-loud or any other strenuous use of my voice without intense coughing) progressed to the point I made an appointment with my primary care physician for 10-20-22. He ran an EKG and a chest x ray. The chest x-ray was clear, but the EKG revealed a Left Bundle Branch Blockage, which had not been noted on any earlier EKGs.  I returned for a follow-up on 10-25-22 for another meeting with Dr. at which time he provided me with the contact information to report this Vaccine Adverse Event. He has also placed in motion additional follow-ups with specialists.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Heart rate increased, Speech disorder
Clinical narrative: I received the Moderna Bivalent AS7162B Vaccine 9-14-22 at the public health clinic. Within days I began experiencing hoarseness and coughing. A key symptom date was 10-10-22. For several years I have checked and recorded blood pressure and pulse rates twice a day. On 10/10/22 my pulse rate made a notable increase. For purposes of comparison, I averaged the pulse rate for 15 days (30 readings) immediately preceding 10-10-22. That average was 73. I then measured pulse ratings for 15 days (30 readings) starting with 10-10-22. That average was 83.   My symptoms (inability to sing, pray audibly, or read out-loud or any other strenuous use of my voice without intense coughing) progressed to the point I made an appointment with my primary care physician for 10-20-22. He ran an EKG and a chest x ray. The chest x-ray was clear, but the EKG revealed a Left Bundle Branch Blockage, which had not been noted on any earlier EKGs.  I returned for a follow-up on 10-25-22 for another meeting with Dr. at which time he provided me with the contact information to report this Vaccine Adverse Event. He has also placed in motion additional follow-ups with specialists.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Bell's palsy, Cerebrovascular accident, Computerised tomogram, Eyelid function disorder
Clinical narrative: On 08/11/2022 I started feeling facial weakness and having a hard time closing my left eye. I was diagnosed with Bells Palsy. About a week later on 8/18/2022 I woke up and had weakness in my legs, face and off balance. I went to the ER and was admitted after they confirmed that it was a stroke. I was prescribed Coditel and advised to stop taking Baby Aspirin. I was discharged after 4 nights.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paresis, Magnetic resonance imaging, Muscular weakness
Clinical narrative: On 08/11/2022 I started feeling facial weakness and having a hard time closing my left eye. I was diagnosed with Bells Palsy. About a week later on 8/18/2022 I woke up and had weakness in my legs, face and off balance. I went to the ER and was admitted after they confirmed that it was a stroke. I was prescribed Coditel and advised to stop taking Baby Aspirin. I was discharged after 4 nights.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Pruritus, Pyrexia
Clinical narrative: Very strong stinging / tingling /itchy feeling of face, neck, chest, arms and a feeling of fever.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was given 0.2 ml of undiluted COVID vaccine.  Tolerated vaccine well.  Spoke with Stepfather on 10/25/22 who reported normal side effects and that child was feeling better by the next day.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Amnesia, Disturbance in attention, Dizziness, Headache, Impaired work ability
Clinical narrative: I had severe headaches, so bad that I vomited, I had body ache, my feet hurt a lot, dizziness, lose focus (10 minutes), memory loss, I can't work anymore. I called my doctor and he immediately he sent me for MRI, and I will have it on 10/28/2022 to see if there is any change in my tumor.  If there is a change, he will refer me to a clinic but have not have any problem with the tumor since I was 10 years old and I had a check also when I was 19. No problems back then, just now again.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head, Pain, Pain in extremity, Vomiting
Clinical narrative: I had severe headaches, so bad that I vomited, I had body ache, my feet hurt a lot, dizziness, lose focus (10 minutes), memory loss, I can't work anymore. I called my doctor and he immediately he sent me for MRI, and I will have it on 10/28/2022 to see if there is any change in my tumor.  If there is a change, he will refer me to a clinic but have not have any problem with the tumor since I was 10 years old and I had a check also when I was 19. No problems back then, just now again.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Moderna  2/27/21  025A21A dose 2 Moderna  3/23/21  045A21A
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Feeling cold, Influenza like illness, Nausea, Shock
Clinical narrative: After going to bed the patient experienced extreme chills, teeth chattering, went into shock, was nauseous, felt extreme flu like symptoms.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, Bacterial infection, Blood glucose abnormal, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider: NP Admission Date: 10/12/2022 Discharge Date: Oct 18, 2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 yo male with PMH of afib, dilated cardiomyopathy, diastolic heart failure, IDDM2, CAD, essential HTN and dementia (non-verbal for last 2 years). He presented to the ED from his home due to fever and after testing positive for COVID-19.   In the ED, patient was noted to be in afib with RVR with CXR without acute cardiopulmonary process. He was treated with Lopressor and initial plan was for discharge back to facility given lack of hypoxia, but heart rate remained >120 and required additional dose of IV Cardizem. Due to difficulty controlling heart rate patient was admitted to the medicine service.   # Chronic Atrial Fibrillation Presented with RVR secondary to COVID-19 infection and home Digoxin was discontinued due to elevated levels. He was continued on his home Xarelto and started on Metoprolol succinate which allowed him to be weaned from Caredizem gtt. Echo was obtained but very limited due to limited views. Patient did develop bradycardia with Metoprolol succinate and therefore dose was reduced at time of discharge.   # COVID-19 PNA with Superimposed Bacterial Infection patient was noted to be hypoxic during hospitalization and therefore started on Decadron and Remdesivir. Repeat CXR demonstrated interstitial opacities and pro-calcitonin was noted to be elevated to 0.66. He completed 1.5 gm of Azithromycin and 5 days of IV Ceftriaxone while hospitalized. He was able to wean off oxygen prior to discharge but was discharged on decadron (6 mg daily) to complete total of 10 days due to inability to verbalize symptoms   # IDDM2 Endocrinology was consulted during hospitalization due to difficulty to control blood sugars secondary to decadron and provided recommendations for discharge.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Condition aggravated, Echocardiogram, Heart rate abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: NP Admission Date: 10/12/2022 Discharge Date: Oct 18, 2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 yo male with PMH of afib, dilated cardiomyopathy, diastolic heart failure, IDDM2, CAD, essential HTN and dementia (non-verbal for last 2 years). He presented to the ED from his home due to fever and after testing positive for COVID-19.   In the ED, patient was noted to be in afib with RVR with CXR without acute cardiopulmonary process. He was treated with Lopressor and initial plan was for discharge back to facility given lack of hypoxia, but heart rate remained >120 and required additional dose of IV Cardizem. Due to difficulty controlling heart rate patient was admitted to the medicine service.   # Chronic Atrial Fibrillation Presented with RVR secondary to COVID-19 infection and home Digoxin was discontinued due to elevated levels. He was continued on his home Xarelto and started on Metoprolol succinate which allowed him to be weaned from Caredizem gtt. Echo was obtained but very limited due to limited views. Patient did develop bradycardia with Metoprolol succinate and therefore dose was reduced at time of discharge.   # COVID-19 PNA with Superimposed Bacterial Infection patient was noted to be hypoxic during hospitalization and therefore started on Decadron and Remdesivir. Repeat CXR demonstrated interstitial opacities and pro-calcitonin was noted to be elevated to 0.66. He completed 1.5 gm of Azithromycin and 5 days of IV Ceftriaxone while hospitalized. He was able to wean off oxygen prior to discharge but was discharged on decadron (6 mg daily) to complete total of 10 days due to inability to verbalize symptoms   # IDDM2 Endocrinology was consulted during hospitalization due to difficulty to control blood sugars secondary to decadron and provided recommendations for discharge.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Lung opacity, Procalcitonin increased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: MD Primary Care Provider: NP Admission Date: 10/12/2022 Discharge Date: Oct 18, 2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 yo male with PMH of afib, dilated cardiomyopathy, diastolic heart failure, IDDM2, CAD, essential HTN and dementia (non-verbal for last 2 years). He presented to the ED from his home due to fever and after testing positive for COVID-19.   In the ED, patient was noted to be in afib with RVR with CXR without acute cardiopulmonary process. He was treated with Lopressor and initial plan was for discharge back to facility given lack of hypoxia, but heart rate remained >120 and required additional dose of IV Cardizem. Due to difficulty controlling heart rate patient was admitted to the medicine service.   # Chronic Atrial Fibrillation Presented with RVR secondary to COVID-19 infection and home Digoxin was discontinued due to elevated levels. He was continued on his home Xarelto and started on Metoprolol succinate which allowed him to be weaned from Caredizem gtt. Echo was obtained but very limited due to limited views. Patient did develop bradycardia with Metoprolol succinate and therefore dose was reduced at time of discharge.   # COVID-19 PNA with Superimposed Bacterial Infection patient was noted to be hypoxic during hospitalization and therefore started on Decadron and Remdesivir. Repeat CXR demonstrated interstitial opacities and pro-calcitonin was noted to be elevated to 0.66. He completed 1.5 gm of Azithromycin and 5 days of IV Ceftriaxone while hospitalized. He was able to wean off oxygen prior to discharge but was discharged on decadron (6 mg daily) to complete total of 10 days due to inability to verbalize symptoms   # IDDM2 Endocrinology was consulted during hospitalization due to difficulty to control blood sugars secondary to decadron and provided recommendations for discharge.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection
Clinical narrative: Discharge Provider: MD Primary Care Provider: NP Admission Date: 10/12/2022 Discharge Date: Oct 18, 2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 yo male with PMH of afib, dilated cardiomyopathy, diastolic heart failure, IDDM2, CAD, essential HTN and dementia (non-verbal for last 2 years). He presented to the ED from his home due to fever and after testing positive for COVID-19.   In the ED, patient was noted to be in afib with RVR with CXR without acute cardiopulmonary process. He was treated with Lopressor and initial plan was for discharge back to facility given lack of hypoxia, but heart rate remained >120 and required additional dose of IV Cardizem. Due to difficulty controlling heart rate patient was admitted to the medicine service.   # Chronic Atrial Fibrillation Presented with RVR secondary to COVID-19 infection and home Digoxin was discontinued due to elevated levels. He was continued on his home Xarelto and started on Metoprolol succinate which allowed him to be weaned from Caredizem gtt. Echo was obtained but very limited due to limited views. Patient did develop bradycardia with Metoprolol succinate and therefore dose was reduced at time of discharge.   # COVID-19 PNA with Superimposed Bacterial Infection patient was noted to be hypoxic during hospitalization and therefore started on Decadron and Remdesivir. Repeat CXR demonstrated interstitial opacities and pro-calcitonin was noted to be elevated to 0.66. He completed 1.5 gm of Azithromycin and 5 days of IV Ceftriaxone while hospitalized. He was able to wean off oxygen prior to discharge but was discharged on decadron (6 mg daily) to complete total of 10 days due to inability to verbalize symptoms   # IDDM2 Endocrinology was consulted during hospitalization due to difficulty to control blood sugars secondary to decadron and provided recommendations for discharge.
Age: 65.0
Sex: M
Vaccine: HEP
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age, Underdose
Clinical narrative: I gave patient the Adolescent dose of 0.5 mL instead of adult dose 1.0mL. Notified clinic manager and patient as soon as error was discovered. Patient returned to clinic, was assessed for any adverse reactions and was administered the 2nd 0.5mL dose to make the correct dose. Patient will receive remainder vaccines according to schedule.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: COVID-19, Cough, Fatigue, Malaise, Pain
Clinical narrative: I still have COVID-19 symptoms. Like the cough, achy, fatigue. The symptoms are not as bad as the first day. These have been the same symptoms from the start but are improving. I started Paxlovid on tuesday and not finished with it yet.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I still have COVID-19 symptoms. Like the cough, achy, fatigue. The symptoms are not as bad as the first day. These have been the same symptoms from the start but are improving. I started Paxlovid on tuesday and not finished with it yet.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: The vaccines were possibly out of temperature due to the move, during hurricane. They were transported in the refrigerator provided by the department of Health with their respective blocks of ice, not accompanied by a thermometer.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Burning sensation, Erythema, Hypersensitivity, Peripheral swelling
Clinical narrative: Pt got the Menactra at 11 year no reaction gave the Menquadfi for 2 dose at 16 years and had allergic reaction with swelling, red and burning on the left arm  On the right arm trumenba had the same reaction not as bad as the menquadfi. We informed them that the menquadfi doesnt need another dose so we dont have to worry about that on but the trumenba needs a booster so we asked them to keep an eye on that arm to see if it gets bigger if it gets to big we might not be able to give the booster asked them to take pictures.  Told them to take cetirizine and called in a steroid cream.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage Administered beyond used date
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray, Chills, Computerised tomogram, Cough, Pneumonia
Clinical narrative: covid booster 10/1/22 cough, chills, fever 10/18/22 dignosed with pneumonia 10/23/22 currently taking  prescribed antibiotic and cough medication 10/26/22
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia
Clinical narrative: covid booster 10/1/22 cough, chills, fever 10/18/22 dignosed with pneumonia 10/23/22 currently taking  prescribed antibiotic and cough medication 10/26/22
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent given in error. No adverse reaction noted.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Pfizer  4/9/21  ER8729 dose 2 Pfizer  5/1/21  ER8735
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: The vaccines were possibly out of temperature due to the move, during hurricane. They were transported in the refrigerator provided by the department of Health with their respective blocks of ice, not accompanied by a thermometer.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Chest X-ray normal, Chronic kidney disease
Clinical narrative: COVID+ 10/15/22 - Vaccination status - pfizer x4   BRIEF OVERVIEW: Discharge Provider: DO  Primary Care Provider at Discharge: MD Discharge disposition: MFB Condition on discharge: Stable.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute kidney injury (HCC) [N17.9] COVID-19 virus infection [U07.1] Generalized weakness [R53.1]   HOSPITAL COURSE: Is a 74-year-old gentleman with a history of AFib on Xarelto, BPH with chronic Foley catheter, insulin-dependent type 2 diabetes, hypertension, sleep apnea, iron deficiency, and bolus pemphigoid on chronic immunosuppression.  He presented to the ER due to generalized weakness and recent fall at home.  Patient had viral symptoms beginning on 10/08.  He had recently started Bactrim, per his urologist, for possible urinary tract infection in setting of new hematuria.  Initial workup in the ER revealed AKI on CKD 4, hyponatremia, and tested positive for COVID-19 on 10/15.  He was admitted to Internal Medicine for workup and therapy evaluation.   Regarding COVID-19 infection, chest x-ray was negative for infiltrates, so patient was treated with supportive care.  He did not require supplemental oxygen.  AKI and acute hypovolemic hyponatremia resolved with IV hydration.  Urinalysis was negative for infection and patient was without hematuria so no further antibiotics were given.  PT/OT evaluated the patient and recommended SAR.  Care manager assisted with placement and patient discharged in stable condition to MFB.   While inpatient he had renal US showing possible renal cysts. Instructed to follow up with PCP for repeat US in 6 months to ensure stability
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Fall, Haematuria, Hyponatraemia, Hypovolaemia
Clinical narrative: COVID+ 10/15/22 - Vaccination status - pfizer x4   BRIEF OVERVIEW: Discharge Provider: DO  Primary Care Provider at Discharge: MD Discharge disposition: MFB Condition on discharge: Stable.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute kidney injury (HCC) [N17.9] COVID-19 virus infection [U07.1] Generalized weakness [R53.1]   HOSPITAL COURSE: Is a 74-year-old gentleman with a history of AFib on Xarelto, BPH with chronic Foley catheter, insulin-dependent type 2 diabetes, hypertension, sleep apnea, iron deficiency, and bolus pemphigoid on chronic immunosuppression.  He presented to the ER due to generalized weakness and recent fall at home.  Patient had viral symptoms beginning on 10/08.  He had recently started Bactrim, per his urologist, for possible urinary tract infection in setting of new hematuria.  Initial workup in the ER revealed AKI on CKD 4, hyponatremia, and tested positive for COVID-19 on 10/15.  He was admitted to Internal Medicine for workup and therapy evaluation.   Regarding COVID-19 infection, chest x-ray was negative for infiltrates, so patient was treated with supportive care.  He did not require supplemental oxygen.  AKI and acute hypovolemic hyponatremia resolved with IV hydration.  Urinalysis was negative for infection and patient was without hematuria so no further antibiotics were given.  PT/OT evaluated the patient and recommended SAR.  Care manager assisted with placement and patient discharged in stable condition to MFB.   While inpatient he had renal US showing possible renal cysts. Instructed to follow up with PCP for repeat US in 6 months to ensure stability
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Ultrasound kidney abnormal, Urine analysis normal
Clinical narrative: COVID+ 10/15/22 - Vaccination status - pfizer x4   BRIEF OVERVIEW: Discharge Provider: DO  Primary Care Provider at Discharge: MD Discharge disposition: MFB Condition on discharge: Stable.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute kidney injury (HCC) [N17.9] COVID-19 virus infection [U07.1] Generalized weakness [R53.1]   HOSPITAL COURSE: Is a 74-year-old gentleman with a history of AFib on Xarelto, BPH with chronic Foley catheter, insulin-dependent type 2 diabetes, hypertension, sleep apnea, iron deficiency, and bolus pemphigoid on chronic immunosuppression.  He presented to the ER due to generalized weakness and recent fall at home.  Patient had viral symptoms beginning on 10/08.  He had recently started Bactrim, per his urologist, for possible urinary tract infection in setting of new hematuria.  Initial workup in the ER revealed AKI on CKD 4, hyponatremia, and tested positive for COVID-19 on 10/15.  He was admitted to Internal Medicine for workup and therapy evaluation.   Regarding COVID-19 infection, chest x-ray was negative for infiltrates, so patient was treated with supportive care.  He did not require supplemental oxygen.  AKI and acute hypovolemic hyponatremia resolved with IV hydration.  Urinalysis was negative for infection and patient was without hematuria so no further antibiotics were given.  PT/OT evaluated the patient and recommended SAR.  Care manager assisted with placement and patient discharged in stable condition to MFB.   While inpatient he had renal US showing possible renal cysts. Instructed to follow up with PCP for repeat US in 6 months to ensure stability
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Fatigue, Headache, Nasopharyngitis, Rhinorrhoea
Clinical narrative: My symptoms started with sinus congestion and runny nose. I thought I had a head cold. I tested positive for COVID-19 on October 20, 2022. I called my doctor. They called me back and asked me a lot of questions. I sent a copy of the test result to them through the portal. They said it was too late for the antiviral medication. They recommended molnupiravir. I took four pills twice a day for 5 days. I took another COVID-19 test this past Monday and still tested positive. I still have a headache, congestion, runny nose, and exhaustion. This morning, I tested positive again.
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: My symptoms started with sinus congestion and runny nose. I thought I had a head cold. I tested positive for COVID-19 on October 20, 2022. I called my doctor. They called me back and asked me a lot of questions. I sent a copy of the test result to them through the portal. They said it was too late for the antiviral medication. They recommended molnupiravir. I took four pills twice a day for 5 days. I took another COVID-19 test this past Monday and still tested positive. I still have a headache, congestion, runny nose, and exhaustion. This morning, I tested positive again.
Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pruritus, Injection site urticaria, Pruritus, Urticaria
Clinical narrative: Hives on bilateral arms, neck, scalp, and torso, very itchy, started at injection site on right arm the day after injection then spread to other areas.  Treating with Prednisone taper, has just begun treatment
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Influenza like illness, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: On Sunday, 9/25/2022, I was having sore throat, achy feeling, like a flu-like feeling and a cough. No fever. It got worse as the day went on. In the evening I tested positive. I called the physician's office on Sunday night, 9/25/22. The PA on call we discussed my symptoms, and he ordered a prescription for PAXLOVID. Which I picked up on Sunday night. The PAXLOVID was for 5 days. I felt pretty good after a couple of days. On the 6th day, I tested again, and I was negative. However, 5 days after that I tested positive again. My symptoms did not come back. I was actually feeling pretty good. I only tested because we were having visitors, and I tested positive. I isolated for 5 days, and after 5 days I tested again, and I tested negative. I am feeling fine now.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent given in error. No adverse reaction noted.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness
Clinical narrative: Patient stated that she felt dizzy after the vaccine and it lasted a few seconds
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Got sick with Covid
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: The vaccines were possibly out of temperature due to the move, during hurricane. They were transported in the refrigerator provided by the Department of Health with their respective blocks of ice, not accompanied by a thermometer.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent given in error. No adverse reaction noted.
Age: 65.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: The influenza vaccine Fluarix and Pneumovax 23 were administered after a temperature excursion that the vaccines were not viable.
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Full blood count, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient was seen today by FNP for swollen red and painful injection site.  She states that her arm has been hurting since 10/20/2022.  She states that she just assumed it was normal injection site pain, but the arm has continued to swell and become reddened.  It has also become very painful. She states that she has also experienced nausea and diarrhea.   She received her vaccine to comply with employment requirements at a pharmacy locally.  After viewing entry in LINKS, there is  not a vaccinator given.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Nausea, Pain in extremity, SARS-CoV-2 test negative
Clinical narrative: Patient was seen today by FNP for swollen red and painful injection site.  She states that her arm has been hurting since 10/20/2022.  She states that she just assumed it was normal injection site pain, but the arm has continued to swell and become reddened.  It has also become very painful. She states that she has also experienced nausea and diarrhea.   She received her vaccine to comply with employment requirements at a pharmacy locally.  After viewing entry in LINKS, there is  not a vaccinator given.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent given in error. No adverse reaction noted.
Age: 13.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dosage administered beyond used date
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Joint stiffness, Joint swelling, Lip swelling, Musculoskeletal stiffness
Clinical narrative: 4th moderna booster received (bivalent) in PM, 2 mornings later had swelling of lip filler sites, whch was place 2 month prior, 2 days after that began with B/L wrist, hands, feet, ankle, SI and neck pain stiffness and swelling, with myalgias of calves and forearms B/L. Lip swelling improved in 1 day - took cetirizine. Arthralgia and myalgias w/ only mild/temporary relief with ibuprofen and Flexeril. Seems to have resolved with Medrol dosepak.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Myalgia, Neck pain, Pain in extremity, Peripheral swelling, Sacral pain
Clinical narrative: 4th moderna booster received (bivalent) in PM, 2 mornings later had swelling of lip filler sites, whch was place 2 month prior, 2 days after that began with B/L wrist, hands, feet, ankle, SI and neck pain stiffness and swelling, with myalgias of calves and forearms B/L. Lip swelling improved in 1 day - took cetirizine. Arthralgia and myalgias w/ only mild/temporary relief with ibuprofen and Flexeril. Seems to have resolved with Medrol dosepak.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Swelling
Clinical narrative: 4th moderna booster received (bivalent) in PM, 2 mornings later had swelling of lip filler sites, whch was place 2 month prior, 2 days after that began with B/L wrist, hands, feet, ankle, SI and neck pain stiffness and swelling, with myalgias of calves and forearms B/L. Lip swelling improved in 1 day - took cetirizine. Arthralgia and myalgias w/ only mild/temporary relief with ibuprofen and Flexeril. Seems to have resolved with Medrol dosepak.
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Swelling
Clinical narrative: localized swelling and redness
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Monovalent given in error. No adverse reaction noted.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Condition aggravated, Dyspnoea, Rash erythematous, Rash pruritic
Clinical narrative: Hot, itchy, red rash. Went into AFIB a few hours later and had difficulty breathing. Rash has lasted five days now. The AFIB and difficulty breathing lasted the rest of the day. I seem to be slowly recovering.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Skin warm
Clinical narrative: Hot, itchy, red rash. Went into AFIB a few hours later and had difficulty breathing. Rash has lasted five days now. The AFIB and difficulty breathing lasted the rest of the day. I seem to be slowly recovering.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: The vaccines were possibly out of temperature due to the move, during hurricane. They were transported in the refrigerator provided by the department of Health with their respective blocks of ice, not accompanied by a thermometer.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Eye irritation, Headache, Hyperaesthesia
Clinical narrative: Starting 10/09/2022, I developed a minor sore throat in the evening. On Monday, it started out as sneezing and a runny nose in the afternoon. Monday evening, I started having body aches along with the sneezing and runny nose. On Tuesday, I woke up with body aches, a fever of 102, minor cough, headache, burning eyes, runny nose and I mostly stayed in bed until mid afternoon. When I did get up, my skin was pretty sensitive to touch. I took a COVID test that day and it was almost instantly positive. I called the doctor that day and they scheduled my telemedicine appointment for that coming Monday and sent a Z-PAK immediately which I started. When I spoke to them, they put me on a steroid (MEDROL dose pack). I slowly got better each day after the telehealth visit. On Thursday, I just had a cough, runny nose and headache. Even today I still have a head cold: Sneezing, coughing and runny nose. I'm slowly getting better but the head cold is lingering.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Starting 10/09/2022, I developed a minor sore throat in the evening. On Monday, it started out as sneezing and a runny nose in the afternoon. Monday evening, I started having body aches along with the sneezing and runny nose. On Tuesday, I woke up with body aches, a fever of 102, minor cough, headache, burning eyes, runny nose and I mostly stayed in bed until mid afternoon. When I did get up, my skin was pretty sensitive to touch. I took a COVID test that day and it was almost instantly positive. I called the doctor that day and they scheduled my telemedicine appointment for that coming Monday and sent a Z-PAK immediately which I started. When I spoke to them, they put me on a steroid (MEDROL dose pack). I slowly got better each day after the telehealth visit. On Thursday, I just had a cough, runny nose and headache. Even today I still have a head cold: Sneezing, coughing and runny nose. I'm slowly getting better but the head cold is lingering.